Medical Cannabis Market Size By Species (Cannabis Indica, Sativa, Hybrid), By Application (Research and Development Centres, Pharmaceutical), And Region For 2024-2031
Report ID: 54873|No. of Pages: 202
Medical Cannabis Market Size By Species (Cannabis Indica, Sativa, Hybrid), By Application (Research and Development Centres, Pharmaceutical), And Region For 2024-2031
Medical Cannabis Market Valuation – 2024-2031
The rapid legalization of medical cannabis across several regions coupled with the growing recognition of its therapeutic benefits is driving a substantial increase in demand for medical cannabis products. Patients are increasingly seeking alternatives to conventional pharmaceuticals, and medical cannabis provides a natural option with various potential health benefits. The global medical cannabis market, valued at USD 34.77 Billion in 2023 is expected to reach approximately USD 164.16 Billion by 2031, largely due to its applications in managing chronic pain, anxiety, and other medical conditions.
Medical cannabis offers a reliable, regulated approach to treating conditions where traditional therapies may fall short, such as epilepsy, multiple sclerosis, and cancer-related symptoms. Furthermore, advancements in cannabinoid research and the development of pharmaceutical-grade cannabis products enhance its appeal to patients and healthcare providers concerned with safety and efficacy. This trend supports market growth, with the sector projected to expand at a CAGR of 21.41% from 2024 to 2031, driven by ongoing research, improved formulations, and increasing product acceptance across demographics.
>>> Download Sample Report @ – https://www.verifiedmarketresearch.com/download-sample/?rid=54873
Medical Cannabis Market: Definition/ Overview
Medical cannabis refers to the range of cannabis-based products including oils, capsules, tinctures, edibles, and topicals formulated specifically for therapeutic purposes to address health conditions such as chronic pain, anxiety, epilepsy, and multiple sclerosis. These products contain active cannabinoids like CBD (cannabidiol) and THC (tetrahydrocannabinol) which are derived from the Cannabis sativa plant. Under medical supervision, they are prescribed to manage specific health issues, often as alternatives or supplements to traditional pharmaceuticals.
The rising demand for medical cannabis is driven by its perceived effectiveness in symptom relief with fewer side effects than some conventional drugs, particularly for pain and mental health management. Cannabinoids like CBD, known for their anti-inflammatory and anti-anxiety properties are increasingly preferred for treating conditions like arthritis, PTSD, and anxiety disorders. Meanwhile, THC formulations provide relief for patients with severe pain, nausea, or appetite loss, commonly benefiting those undergoing chemotherapy or managing severe chronic conditions.
In the coming years, the medical cannabis is expected to be shaped by advancements in product innovation, regulatory standards, and clinical research. Innovations in precise dosage forms, such as transdermal patches, inhalers, and specialized edibles will offer patients improved options for managing symptoms more effectively. Additionally, further genetic research on cannabis strains will enable the cultivation of plants with specific cannabinoid profiles, optimizing their efficacy for targeted treatments.
What's inside a VMR
industry report?
Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.
>>> Ask For Discount @ – https://www.verifiedmarketresearch.com/ask-for-discount/?rid=54873
Will the Rising Demand for Alternative Therapies Drive the Medical Cannabis Market?
The medical cannabis market is expanding as demand for alternative therapies increases, particularly for chronic pain, mental health conditions, and neurological disorders. Medical cannabis offers a natural, plant-based treatment option appealing to patients and healthcare providers looking for non-opioid solutions. For instance, data from New Frontier Data reveals that in North America alone, over 50% of patients use cannabis for pain management, with 22% seeking it for mental health issues underscoring the role of cannabis in alternative medicine.
Legislative advancements, such as the legalization of medical cannabis in countries like Germany, Canada, and certain U.S. states, are further fueling this trend. These factors collectively establish medical cannabis as an increasingly critical option in modern healthcare driving market growth.
Will Regulatory Compliance and High Costs Hinder the Medical Cannabis Market?
Regulatory compliance and high operational costs could restrict the growth of the medical cannabis market as companies face challenges adhering to complex legal requirements across regions. Strict regulations such as those under the U.S. FDA and the European Medicines Agency (EMA), require comprehensive clinical trials and rigorous documentation resulting in substantial costs. Moreover, regional disparities in cannabis legality create compliance hurdles for companies looking to expand internationally. According to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), extensive regulatory requirements add an estimated 25-30% to operating costs for companies in the sector. These high compliance costs and regulatory challenges may slow market growth making it difficult for smaller players to enter or expand within the industry.
Category-Wise Acumens
Will the Increasing Scalability and Flexibility of Cannabis Indica Drive Its Dominance in the Global Medical Cannabis Market?
Cannabis indica is expected to maintain its dominant position in the global medical cannabis market, driven by its scalability and flexibility in addressing various medical conditions. The strain’s therapeutic properties are highly sought after for managing chronic pain, anxiety, and sleep disorders appealing to a broad patient base. As healthcare providers increasingly recognize the benefits of cannabis-based treatments, the demand for Cannabis indica products is projected to rise. This growth is further fueled by ongoing research supporting its efficacy leading to greater acceptance and utilization in medical settings.
Will the Increasing Focus on Research and Development Drive the Application of Medical Cannabis in Pharmaceutical Settings?
The application of medical cannabis is expected to grow significantly within pharmaceutical settings driven by an increasing focus on research and development. As pharmaceutical companies invest in exploring the therapeutic potential of cannabis, particularly for conditions like chronic pain, epilepsy, and multiple sclerosis, the demand for cannabis-based medications is projected to rise. This emphasis on R&D not only fosters innovation in drug formulations but also enhances regulatory acceptance encouraging healthcare professionals to incorporate medical cannabis into treatment regimens. Consequently, the evolving landscape of pharmaceutical applications is set to play a pivotal role in the expansion of the medical cannabis market.
Gain Access into Medical Cannabis Market Report Methodology
https://www.verifiedmarketresearch.com/select-licence/?rid=54873
Country/Region-wise Acumens
Will North America Continue to Dominate the Medical Cannabis Market Due to Favourable Legalization and Investment Trends?
North America leads the medical cannabis market, driven by a supportive regulatory environment, significant R&D investments, and a robust infrastructure. The region accounted for approximately 70% of the global medical cannabis market revenue in 2023 largely due to the extensive legalization and acceptance of cannabis for medical use. In the U.S., over 38 states have legalized medical cannabis creating a vast market base, while Canada has operated a legal federally regulated medical cannabis market since 2001.
Additionally, North America invests heavily in R&D, with a focus on clinical trials and product innovations tailored to treat conditions such as chronic pain, anxiety, and epilepsy. The U.S. National Institute on Drug Abuse (NIDA) and private firms spend an estimated $200 million annually on cannabis research, fueling advancements in formulations and delivery systems. The region’s well-developed distribution channels and consumer awareness support a steady growth in demand. North America’s advanced healthcare system, coupled with educational initiatives about cannabis’ potential medical benefits further drives market expansion.
Will the Growing Acceptance of Medical Cannabis Drive the Market in the Asia Pacific Region?
The Asia Pacific region is poised to experience significant growth in the medical cannabis market, largely driven by the increasing acceptance and legalization of cannabis for medical use. This trend is particularly evident in countries like Thailand and South Korea which have implemented progressive policies. According to a recent report, the medical cannabis market in the Asia Pacific region is projected to grow at a compound annual growth rate (CAGR) of approximately 34% from 2024 to 2031.The shift in public perception and legislative changes are crucial drivers of this market expansion. Thailand made headlines by becoming the first Southeast Asian country to legalize medical cannabis in 2018, promoting its use for various medical conditions and supporting research initiatives.
Moreover, the rising prevalence of chronic diseases and an aging population are further fuelling the demand for medical cannabis treatments in the region. As healthcare systems evolve, more patients are seeking alternative therapies leading to increased acceptance among healthcare professionals and the general public. The growing awareness of the potential benefits of medical cannabis is transforming the Asia Pacific region into a significant market for cannabis-based products positioning it for rapid growth in the coming years.
Competitive Landscape
The Medical Cannabis Market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support. The organizations are focusing on innovating their product line to serve the vast population in diverse regions.
Some of the prominent players operating in the medical cannabis market include:
BOL Pharma, Tilray, Medreleaf Corporation, Aurora Cannabis, Inc., Canopy Growth Corporation, Insys Therapeutics, Inc., Aphria, Inc., MGC Pharmaceuticals Limited.
Latest Developments
- In March 2023, Jazz Pharmaceuticals collaborated with a leading research institution to explore medical cannabis’s effectiveness in treating anxiety disorders. This partnership is expected to drive breakthrough clinical research and generate valuable insights into the therapeutic potential of cannabis for mental health conditions, addressing a growing demand among healthcare providers for alternative anxiety treatments.
- In February 2023, Cronos Group finalized its acquisition of Redwood Holding Group, significantly expanding its product portfolio and solidifying its position in the medical cannabis market. This strategic acquisition broadens Cronos Group’s reach in the health and wellness segment, allowing the company to meet rising consumer demand with a more diversified range of cannabis-based therapeutic products.
- In January 2023, GW Pharmaceuticals launched a new line of medical cannabis treatments targeted at pediatric epilepsy. This product line meets the rising demand for effective cannabis-based therapies in pediatric care, offering a safe, natural treatment alternative for children with chronic epilepsy. GW Pharmaceuticals’ innovation reflects the expanding scope of medical cannabis, highlighting its promise across diverse patient demographics in the healthcare industry.
Report Scope
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2018-2031 |
| Growth Rate | CAGR of ~21.41% from 2024 to 2031 |
| Base Year for Valuation | 2023 |
| Historical Period | 2018-2022 |
| Forecast Period | 2024-2031 |
| Quantitative Units | Value in USD Billion |
| Report Coverage | Historical and Forecast Revenue Forecast, Historical and Forecast Volume, Growth Factors, Trends, Competitive Landscape, Key Players, Segmentation Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Players |
|
| Customization | Report customization along with purchase available upon request |
Medical Cannabis Market, By Category
Species:
- Cannabis Indica
- Sativa
- Hybrid
Application:
- Research And Development Centers
- Pharmaceutical
Region:
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Research Methodology of Verified Market Research:
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our Sales Team at Verified Market Research.
Reasons to Purchase this Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Customization of the Report
• In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.
Frequently Asked Questions
1 INTRODUCTION OF GLOBAL MEDICAL CANNABIS MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL MEDICAL CANNABIS MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
5 GLOBAL MEDICAL CANNABIS MARKET, BY SPECIES
5.1 Overview
5.2 Cannabis Indica
5.3 Sativa
5.4 Hybrid
6 GLOBAL MEDICAL CANNABIS MARKET, BY APPLICATION
6.1 Overview
6.2 Research And Development Centers
6.3 Pharmaceutical
6.4 Others
7 GLOBAL MEDICAL CANNABIS MARKET, BY GEOGRAPHY
7.1 Overview
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 U.K.
7.3.3 France
7.3.4 Rest of Europe
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Rest of Asia Pacific
7.5 Rest of the World
7.5.1 Latin America
7.5.2 Middle East & Africa
8 GLOBAL MEDICAL CANNABIS MARKET COMPETITIVE LANDSCAPE
8.1 Overview
8.2 Company Market ranking
8.3 Key Development Strategies
9 COMPANY PROFILES
9.1 BOL Pharma
9.1.1 Overview
9.1.2 Financial Performance
9.1.3 Product Outlook
9.1.4 Key Developments
9.2 Tilray
9.2.1 Overview
9.2.2 Financial Performance
9.2.3 Product Outlook
9.2.4 Key Developments
9.3 Medreleaf Corporation
9.3.1 Overview
9.3.2 Financial Performance
9.3.3 Product Outlook
9.3.4 Key Developments
9.4 Aurora Cannabis, Inc
9.4.1 Overview
9.4.2 Financial Performance
9.4.3 Product Outlook
9.4.4 Key Developments
9.5 Canopy Growth Corporation
9.5.1 Overview
9.5.2 Financial Performance
9.5.3 Product Outlook
9.5.4 Key Developments
9.6 Insys Therapeutics, Inc
9.6.1 Overview
9.6.2 Financial Performance
9.6.3 Product Outlook
9.6.4 Key Developments
9.7 Aphria, Inc
9.7.1 Overview
9.7.2 Financial Performance
9.7.3 Product Outlook
9.7.4 Key Developments
9.8 MGC Pharmaceuticals Limited
9.8.1 Overview
9.8.2 Financial Performance
9.8.3 Product Outlook
9.8.4 Key Developments
9.9 GW Pharmaceuticals
9.9.1 Overview
9.9.2 Financial Performance
9.9.3 Product Outlook
9.9.4 Key Developments
9.10 Medical Marijuana Inc.
9.10.1 Overview
9.10.2 Financial Performance
9.10.3 Product Outlook
9.10.4 Key Developments
10 APPENDIX
10.1 Related Research
Report Research Methodology
Verified Market Research uses the latest researching tools to offer accurate data insights. Our experts deliver the best research reports that have revenue generating recommendations. Analysts carry out extensive research using both top-down and bottom up methods. This helps in exploring the market from different dimensions.
This additionally supports the market researchers in segmenting different segments of the market for analysing them individually.
We appoint data triangulation strategies to explore different areas of the market. This way, we ensure that all our clients get reliable insights associated with the market. Different elements of research methodology appointed by our experts include:
Exploratory data mining
Market is filled with data. All the data is collected in raw format that undergoes a strict filtering system to ensure that only the required data is left behind. The leftover data is properly validated and its authenticity (of source) is checked before using it further. We also collect and mix the data from our previous market research reports.
All the previous reports are stored in our large in-house data repository. Also, the experts gather reliable information from the paid databases.
For understanding the entire market landscape, we need to get details about the past and ongoing trends also. To achieve this, we collect data from different members of the market (distributors and suppliers) along with government websites.
Last piece of the ‘market research’ puzzle is done by going through the data collected from questionnaires, journals and surveys. VMR analysts also give emphasis to different industry dynamics such as market drivers, restraints and monetary trends. As a result, the final set of collected data is a combination of different forms of raw statistics. All of this data is carved into usable information by putting it through authentication procedures and by using best in-class cross-validation techniques.
Data Collection Matrix
| Perspective | Primary Research | Secondary Research |
|---|---|---|
| Supplier side |
|
|
| Demand side |
|
|
Econometrics and data visualization model
Our analysts offer market evaluations and forecasts using the industry-first simulation models. They utilize the BI-enabled dashboard to deliver real-time market statistics. With the help of embedded analytics, the clients can get details associated with brand analysis. They can also use the online reporting software to understand the different key performance indicators.
All the research models are customized to the prerequisites shared by the global clients.
The collected data includes market dynamics, technology landscape, application development and pricing trends. All of this is fed to the research model which then churns out the relevant data for market study.
Our market research experts offer both short-term (econometric models) and long-term analysis (technology market model) of the market in the same report. This way, the clients can achieve all their goals along with jumping on the emerging opportunities. Technological advancements, new product launches and money flow of the market is compared in different cases to showcase their impacts over the forecasted period.
Analysts use correlation, regression and time series analysis to deliver reliable business insights. Our experienced team of professionals diffuse the technology landscape, regulatory frameworks, economic outlook and business principles to share the details of external factors on the market under investigation.
Different demographics are analyzed individually to give appropriate details about the market. After this, all the region-wise data is joined together to serve the clients with glo-cal perspective. We ensure that all the data is accurate and all the actionable recommendations can be achieved in record time. We work with our clients in every step of the work, from exploring the market to implementing business plans. We largely focus on the following parameters for forecasting about the market under lens:
- Market drivers and restraints, along with their current and expected impact
- Raw material scenario and supply v/s price trends
- Regulatory scenario and expected developments
- Current capacity and expected capacity additions up to 2027
We assign different weights to the above parameters. This way, we are empowered to quantify their impact on the market’s momentum. Further, it helps us in delivering the evidence related to market growth rates.
Primary validation
The last step of the report making revolves around forecasting of the market. Exhaustive interviews of the industry experts and decision makers of the esteemed organizations are taken to validate the findings of our experts.
The assumptions that are made to obtain the statistics and data elements are cross-checked by interviewing managers over F2F discussions as well as over phone calls.
Different members of the market’s value chain such as suppliers, distributors, vendors and end consumers are also approached to deliver an unbiased market picture. All the interviews are conducted across the globe. There is no language barrier due to our experienced and multi-lingual team of professionals. Interviews have the capability to offer critical insights about the market. Current business scenarios and future market expectations escalate the quality of our five-star rated market research reports. Our highly trained team use the primary research with Key Industry Participants (KIPs) for validating the market forecasts:
- Established market players
- Raw data suppliers
- Network participants such as distributors
- End consumers
The aims of doing primary research are:
- Verifying the collected data in terms of accuracy and reliability.
- To understand the ongoing market trends and to foresee the future market growth patterns.
Industry Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|---|---|
|
|
